Ebitda Perubahan Tanggal
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Amgen USD 5.8B 1.25B 2026-09
Arca Biopharma USD -25.07M 5.23M 2025-03
Bayer EUR 1.62B 529M 2026-09
Biogen USD 450.8M 198.9M 2026-06
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cytokinetics USD -160.3M 9.02M 2026-06
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Geron USD -9.2M 13.03M 2026-06
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09